Top insights from the latest market news from Thursday, March 27, from The Motley Fool analysts on Team Rule Breakers and ...

This spine-focused medtech firm, known for its surgical innovations, reported a notable insider sale amid ongoing portfolio expansion.

Trader barriers are increasing import prices for most businesses, including e.l.f.

If you don't yet have exposure to either coin, it's worth buying $500 of each, provided that your portfolio is already diversified with safer investments. If you want to pick just one to invest $1,000 ...

At some point over the past year, the stock market went from cheering increases in spending for artificial intelligence (AI) ...

While no single company owns the entire artificial intelligence (AI) technology stack, if you want exposure to a wide swath ...

At $1.75 trillion, SpaceX would surpass Saudi Aramco's record-setting $1.7 trillion market debut in 2019. However, that would ...

This annuities and life insurance provider saw a notable insider buy amid a year marked by sharp share price declines and sector headwinds.

This biotech innovator in genetic disease therapies reported a notable insider sale amid a year of dramatic share price gains.

If you're looking for stocks to buy right now, I've got three stocks that look like strong investment options. All three are ...

LeMaitre Vascular, a specialist in vascular medical devices, reported a notable insider sale amid strong recent share gains.